Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 272-276

  Momiyama, Yukihiko ^a   Kawaguchi, Akito ^b   Kajiwara, Ichiro ^c   Ohmori, Reiko ^d   Okada, Katsutoshi ^e   Saito, Isao ^e   Konishi, Masamitsu ^f   Nakamura, Masakazu ^f   Sato, Shinichi ^g   Kokubo, Yoshihiro ^h   Mannami, Toshifumi ⁱ   Adachi, Hisashi ^j   Kario, Kazuomi ^k   Iso, Hiroyasu ^l   Ohsuzu, Fumitaka ^d   Tsushima, Motoo ^m  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^g CHIBA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^h NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

ⁱ Asada General Hospital   (Japan)

^j KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k JICHI MEDICAL UNIVERSITY   (Japan)

^l OSAKA UNIVERSITY   (Japan)

^m KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

C reactive protein; Cardiovascular events; Coronary artery disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANGIOCARDIOGRAPHY; AORTA DISEASE; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR AGENTS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 70350570585     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.015     Document Type: Article

References (32)

1. Alexander R.W. Inflammation and coronary heart disease. N Engl J Med 331 (1994) 468-549
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Eng J Med 336 (1997) 973-979
4. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
5. Koenig W., Sund M., Frohlich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study 1984 to 1992. Circulation 99 (1999) 237-242
6. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Eng J Med 331 (1994) 417-424
7. Haverkate F., Thompson S.G., Pyke S.D.M., et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349 (1997) 462-466
8. Zebrack J.S., Muhlestein J.B., Horne B.D., et al. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39 (2002) 632-637
9. Albert M.A., Glynn R.J., Buring J., and Ridker P.M. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93 (2004) 1238-1242
10. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 (2005) 464-469
11. Saito I., Sato S., Nakamura M., et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 194 (2007) 238-244
12. Yamada S., Gotoh T., Nakashima Y., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 153 (2001) 1183-1190
13. Ichihara K., Itoh Y., Min W.K., et al. Diagnostic and epidemiological implications of regional differences in serum concentrations of proteins observed in six Asian cities. Clin Chem Lab Med 42 (2004) 800-809
14. Taniguchi H., Momiyama Y., Ohmori R., et al. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 178 (2005) 173-177
15. Arima H., Kubo M., Yonemoto K., et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: The Hisayama Study. Arterioscler Thromb Vasc Biol 28 (2008) 1385-1391
16. Nakamura M., Sato S., and Shimamoto T. Establishment of external quality control program for hsCRP and three-year follow-up of the performance for precision and accuracy. J Atheroscler Thromb 14 (2007) 287-293
17. Khor L.L.C., Muhlestein J.B., Carlquist J.F., et al. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med 117 (2004) 657-664
18. Horne B.D., Muhlestein J.B., Carlquist J.F., et al. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol 36 (2000) 1774-1780
19. Buffon A., Liuzzo G., Biasucci L.M., et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34 (1999) 1512-1521
20. de Winter R.J., Koch K.T., van Straalen J.P., et al. C-reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med 115 (2003) 85-90
21. Walter D.H., Fichtlscherer S., Sellwig M., et al. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
22. Zairis M.N., Ambrose J.A., Manousakis S.J., et al. The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting. J Am Coll Cardiol (2002) 1375-1382
23. Leu H.B., Lin C.P., Lin W.T., Wu T.C., and Chen J.W. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: The role of high-sensitivity C-reactive protein. Chest 126 (2004) 1032-1039
24. Sabatine M.S., Morrow D.A., Jablonski K.A., et al. Prognostic significance of the centers for disease control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 (2007) 1528-1536
25. Speidl W.S., Graf S., Hornykewycz S., et al. High sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J 144 (2002) 449-455
26. Ikonomidis I., Lekakis J., Revela I., Andreotti F., and Nihoyannopoulos P. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease. Eur Heart J 26 (2005) 1618-1624
27. de Winter R.J., Heyde G.S., Koch K.T., et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasly. Eur Heart J 23 (2002) 960-966
28. Dibra A., Mehilli J., Braun S., et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722
29. Berk B.C., Weintraub W.S., and Alexander R.W. Elevation of C-reactive protein in active coronary artery disease. Am J Cardiol 65 (1990) 168-172
30. Rotterstol L., Eikvar L., and Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169 (2003) 279-282
31. Zee R.Y.L., and Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP and the risk of future arterial thrombosis. Atherosclerosis 162 (2002) 217-219
32. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511